Quintrio
Home

HOSPITAL & MEDICAL SERVICE PLANS

Molina Healthcare, Inc.

MOH

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.

Last trade $225.07
Day change -$8.02 (-3.44%)
Day range $223.97 – $232.07
Volume 445,205
Market cap $12.17B

Open XNYS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$12.17B
Price / earnings
—
Price / book
2.93×
Price / sales
0.28×
EV / sales
0.27×
EV / EBITDA
204.18×

Profitability

Earnings per share
-$0.92
Return on assets
-0.31%
Return on equity
-1.16%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.95×
Current ratio
1.69×
Quick ratio
1.69×
Cash ratio
0.61×

Cash flow

Price / cash flow
36.76×
Price / free cash flow
51.12×
Free cash flow
$238M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for MOH, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$10.96B$10.75B$10.68B$11.44B$11.35B$11.3B$11.02B$10.56B
Cost of revenue$9.72B$9.44B$9.27B$10.14B$10.04B$9.83B$9.48B$9B
Gross profit$1.24B$1.31B$1.41B$1.31B$1.3B$1.47B$1.54B$1.56B
Selling, general and administrative$710M$724M$779M$795M$729M$711M$774M$665M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$1.26B$1.29B$1.44B$1.47B$1.3B$1.23B$1.24B$1.2B
Operating income-$19M$20M-$37M-$161M$7M$245M$302M$363M
Interest expense-$53M-$54M-$54M-$52M-$49M-$48M-$43M-$34M
Income before taxes$53M$91M$29M-$214M$88M$325M$390M$346M
Income taxes$15M$31M$15M-$54M$9M$70M$92M$95M
Net income$38M$60M$14M-$160M$79M$255M$298M$251M
Net income attributable to common shareholders$38M$60M$14M-$160M$79M$255M$298M$251M
EBITDA$19M$60M$95M-$117M$52M$303M$350M$411M
Basic earnings per share$0.74$1.19$0.27-$3.17$1.51$4.75$5.47$4.48
Diluted earnings per share$0.73$1.19$0.27-$3.16$1.51$4.75$5.45$4.43

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Can Medicaid Rate Improvements Drive Elevance's 2027 Margin Recovery?

Elevance Health expects Medicaid margins to improve in 2027 through higher reimbursement rates and cost management, with Q3 Medicaid revenues reaching $15 billion. However, rate increases remain uneven across states and may not fully offset elevated medical costs. Peers Centene and Molina face similar pressures, with mixed results in converting premium growth to profitability.

Zacks Investment Research

Cigna Q3 Earnings Top Estimates on Cigna Healthcare Strength

Cigna Group reported Q3 2026 adjusted EPS of $7.98, beating estimates by 7%, with revenues growing 6.1% to $73.8B. Cigna Healthcare segment showed strong performance with 8.9% revenue growth and 14.9% operating income growth. The company raised its 2026 adjusted EPS outlook to at least $30.60 and Cigna Healthcare's operating income target to $4.6B. However, Evernorth Health Services missed revenue estimates and Pharmacy Benefit Services contributed less than expected.

The Motley Fool

Molina: 3 Key Takeaways for Long-Term Investors

Molina Healthcare reaffirmed its full-year 2026 adjusted earnings guidance of at least $5.25 per share on its Q3 earnings call. The company is seeing state Medicaid reimbursement rates align with elevated care costs, signaling a potential trough in margins and the beginning of a multiyear recovery cycle. Management expects $4 per share in embedded earnings from contract backlogs in 2027, including a $6 billion Florida specialized children's health program, with state work requirement implementations showing moderate member attrition.

Zacks Investment Research

Lucie and CHOICE Broaden the Growth Runway for Oscar Health

Oscar Health is diversifying revenue streams beyond ACA insurance through Lucie, an enhanced direct enrollment platform targeting a $650+ billion marketplace, and CHOICE, which capitalizes on growing ICHRA adoption. While the company has gained 116.1% year-to-date, its stock trades at a premium valuation (P/E of 14.17 vs. industry average of 9.02) with consensus estimates showing projected revenue and earnings decreases for 2026-2027.

Zacks Investment Research

Centene to Report Q3 Earnings: Buy, Sell or Hold the Stock?

Centene Corporation (CNC) is set to report Q3 2026 earnings on Oct. 27 with projected EPS of 7 cents and revenues of $47.06B, both declining year-over-year. While the company benefits from improving Medicaid margins and Marketplace profitability, it faces headwinds from shrinking commercial and Medicaid memberships. The stock has rallied 70.7% YTD but trades at elevated valuations relative to historical levels. Existing investors may hold positions while new investors should await better entry points.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
May 23, 20113-for-2forward split